Inflammasome activation in an SIV-ART model of chronic drug abuse
慢性药物滥用 SIV-ART 模型中的炎症小体激活
基本信息
- 批准号:9934585
- 负责人:
- 金额:$ 71.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-30 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS dementiaAdherenceAffectAgeAnimal ModelAnimalsAstrocytesAtherosclerosisBlood - brain barrier anatomyBrainCASP1 geneCCL2 geneCell Culture TechniquesCellsCentral Nervous System DiseasesChronicCocaineCocaine DependenceDNADataDiabetes MellitusDiagnosisDiseaseDrug abuseDrug usageExposure toHIVHIV InfectionsHIV-1HIV-associated neurocognitive disorderHumanImmune responseImmune systemImmunosuppressionImpairmentIncidenceIndividualInfectionInflammasomeInflammationInflammatoryInterleukin-1 betaInterleukin-18Kidney DiseasesLiver diseasesLymphocyteMacacaMacaca mulattaMaintenanceMeasuresMediatingMicrogliaModelingMorbidity - disease rateMorphineMorphine AbuseMusNeurocognitive DeficitOpioidPathogenesisPatientsPenetrationPeripheralPharmaceutical PreparationsPredispositionRNARoleSIVTimeTissuesViralViral GenomeViral ProteinsViral reservoirVirus DiseasesVirus Latencyacute infectioncocaine exposurecocaine usecytokinedrug of abuseinsightmacrophagemathematical modelmigrationmonocytemorphine administrationmortalitynon-drugnovelopioid abuserecruitresponsesynergismtool
项目摘要
PROJECT SUMMARY
HIV/SIV infects microglia and astrocytes in the CNS during acute infection establishing viral reservoirs and
causing CNS inflammation mediated by activation of inflammasomes. Prior to ART, severe HIV-associated
dementia (HAD) occurred in approximately one-third of infected patients. Although ART has led to marked
decrease in HAD, milder forms of HIV-associated neurocognitive disorders (HAND) are still diagnosed in 50%
of infected ART-treated individuals. Although ART reduced the incidence of HIV-related morbidity and mortality,
there is evidence that chronic inflammatory diseases occur more frequently and/or at earlier ages in HIV-
infected individuals. The pathogenesis of HAND is unclear, though chronic inflammation induced by long-term
infection and drug abuse may be contributing factors. Inflammation associated with viral infections is caused by
activation of inflammasomes. Inflammasome assembly results in recruitment and activation of caspase-1 and
cleavage of the pro-forms of IL-1β and IL-18 into active, secreted cytokines. IL-1β and IL-18 are
proinflammatory cytokines known to mediate inflammation. However, the role of elevated IL-18 in HIV CNS
disease is not clear, especially in the context of chronic drug abuse. The effects of commonly used drugs of
abuse, cocaine and morphine, on inflammasome activation in brain during HIV/SIV infection have not been
rigorously examined. We propose to examine effects of cocaine and morphine on activation of inflammasomes
and viral infection in the SIVmac251 infected rhesus macaque model with and without ART. Our studies
suggest cocaine and morphine affect inflammasome activation in SIV infection. Long-term exposure to cocaine
or morphine before/after SIV infection leads to elevated levels of IL-18 in CSF compared to infected animals
without drugs. We propose to study the effects of chronic cocaine and chronic morphine exposure on CNS
inflammasome activation in ART suppressed SIV infected macaques. We also propose to examine, for the first
time, effects of inflammasome activation during acute infection and the effects of cocaine and morphine on the
seeding of SIV infection in brain. We hypothesize that SIV infection in brain results in high levels of
inflammasome activation, and that chronic exposure to cocaine or morphine will modulate inflammasome
activation in brain. Specific Aim 1 will determine if chronic cocaine or morphine administration alters SIV-
induced inflammasome activation in the CNS. Specific Aim 2 will determine if chronic morphine or cocaine
administration in ART-suppressed SIV-infected macaques affects inflammasome activation. Specific Aim 3
will examine whether chronic cocaine or morphine treatment alters the progression of SIV infection and/or the
establishment of/or maintenance of viral reservoirs in brain.
项目概要
HIV/SIV 在急性感染期间感染中枢神经系统中的小胶质细胞和星形胶质细胞,建立病毒库并
引起由炎症小体激活介导的中枢神经系统炎症。在接受 ART 治疗之前,患有严重 HIV 相关疾病的
大约三分之一的感染患者出现痴呆症(HAD)。尽管 ART 已导致显着
HAD 减少,但 50% 的人仍被诊断出较轻形式的 HIV 相关神经认知障碍 (HAND)
接受 ART 治疗的受感染个体。尽管抗逆转录病毒治疗降低了艾滋病毒相关的发病率和死亡率,
有证据表明,慢性炎症性疾病在 HIV 感染者中发生得更频繁和/或发生得更早。
感染者。 HAND 的发病机制尚不清楚,但长期的慢性炎症会导致 HAND
感染和药物滥用可能是促成因素。与病毒感染相关的炎症是由
炎症小体的激活。炎症小体组装导致 caspase-1 的募集和激活
将 IL-1β 和 IL-18 的前体裂解为活性的分泌细胞因子。 IL-1β 和 IL-18 是
已知可介导炎症的促炎细胞因子。然而,升高的 IL-18 在 HIV 中枢神经系统中的作用
疾病尚不清楚,特别是在长期滥用药物的情况下。常用药物的作用
滥用可卡因和吗啡对 HIV/SIV 感染期间大脑炎症小体激活的影响尚未得到证实
严格审查。我们建议检查可卡因和吗啡对炎症小体激活的影响
以及使用或不使用 ART 的 SIVmac251 感染恒河猴模型中的病毒感染。我们的研究
表明可卡因和吗啡影响 SIV 感染中炎症小体的激活。长期接触可卡因
与感染动物相比,SIV 感染前后服用吗啡会导致脑脊液中 IL-18 水平升高
没有药物。我们建议研究长期可卡因和吗啡暴露对中枢神经系统的影响
ART 中炎症小体的激活抑制了 SIV 感染的猕猴。我们还建议首先审查
时间、急性感染期间炎症小体激活的影响以及可卡因和吗啡对
SIV 感染在大脑中播种。我们假设大脑中的 SIV 感染会导致高水平的
炎症小体激活,长期接触可卡因或吗啡会调节炎症小体
大脑中的激活。具体目标 1 将确定长期服用可卡因或吗啡是否会改变 SIV-
诱导中枢神经系统炎症小体激活。具体目标 2 将确定是否慢性吗啡或可卡因
ART 抑制的 SIV 感染猕猴中的给药会影响炎症小体的激活。具体目标 3
将检查长期可卡因或吗啡治疗是否会改变 SIV 感染的进展和/或
在大脑中建立/或维持病毒库。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JANICE E CLEMENTS其他文献
JANICE E CLEMENTS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JANICE E CLEMENTS', 18)}}的其他基金
Inflammasome activation in an SIV-ART model of chronic drug abuse
慢性药物滥用 SIV-ART 模型中的炎症小体激活
- 批准号:
10453622 - 财政年份:2019
- 资助金额:
$ 71.59万 - 项目类别:
Inflammasome activation in an SIV-ART model of chronic drug abuse
慢性药物滥用 SIV-ART 模型中的炎症小体激活
- 批准号:
10668258 - 财政年份:2019
- 资助金额:
$ 71.59万 - 项目类别:
Inflammasome activation in an SIV-ART model of chronic drug abuse
慢性药物滥用 SIV-ART 模型中的炎症小体激活
- 批准号:
10217087 - 财政年份:2019
- 资助金额:
$ 71.59万 - 项目类别:
Inflammasome activation in an SIV-ART model of chronic drug abuse
慢性药物滥用 SIV-ART 模型中的炎症小体激活
- 批准号:
10017037 - 财政年份:2019
- 资助金额:
$ 71.59万 - 项目类别:
Modeling HIV Rebound: Role of SIVmac251 Functional Reservoirs and Biomarkers of Reactivation
HIV 反弹建模:SIVmac251 功能库和重新激活生物标志物的作用
- 批准号:
9322137 - 财政年份:2017
- 资助金额:
$ 71.59万 - 项目类别:
Plasma miRNA Biomarkers of HIV/SIV CNS Disease
HIV/SIV CNS 疾病的血浆 miRNA 生物标志物
- 批准号:
8916196 - 财政年份:2012
- 资助金额:
$ 71.59万 - 项目类别:
Plasma miRNA Biomarkers of HIV/SIV CNS Disease
HIV/SIV CNS 疾病的血浆 miRNA 生物标志物
- 批准号:
8408857 - 财政年份:2012
- 资助金额:
$ 71.59万 - 项目类别:
相似海外基金
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 71.59万 - 项目类别:
Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 71.59万 - 项目类别:
Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 71.59万 - 项目类别:
Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 71.59万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 71.59万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 71.59万 - 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 71.59万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 71.59万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 71.59万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 71.59万 - 项目类别:
Fellowship Programs